Obese Type 2 Diabetes Patients May Find Promising Therapy in EndoBarrier Combined with Liraglutide
News
GI Dynamics recently announced new data from the REVISE Diabesity study, revealing that obese type 2 diabetes patients treated with EndoBarrier Therapy (EBT) plus liraglutide, a medicine prescribed to lower blood ... Read more